483 Smithfield Bioscience Nov 2014

483 Smithfield Bioscience Nov 2014

Nicholas Paulin FDA$119.00 - Available Now

FDA investigators audited the Smithfield Bioscience - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 14 Nov 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Nov 2014
  • Location: Cincinnati, United States
  • FEI: 1527761
Add To Cart